A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention

P Su, Y Wu, F Xie, Q Zheng, L Chen, Z Liu… - Advanced …, 2023 - Wiley Online Library
The 2019 novel coronavirus disease (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is ongoing, and has necessitated …

Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19

Z Hu, W Wang, Y Lin, H Guo, Y Chen… - Advanced Healthcare … - Wiley Online Library
Emerging infectious diseases like Coronavirus pneumonia (COVID‐19) present significant
challenges to global health, extensively affecting both human society and the economy …

Extracellular vesicles as a translational approach for the treatment of COVID-19 disease: an updated overview

E Serretiello, A Ballini, A Smimmo, M Acunzo, M Raimo… - Viruses, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic
in the years 2020–2022. With a high prevalence, an easy route of transmission, and a long …

Extracellular vesicle-based therapy for COVID-19: Promises, challenges and future prospects

V Karn, S Ahmed, LW Tsai, R Dubey, S Ojha, HN Singh… - Biomedicines, 2021 - mdpi.com
The COVID-19 pandemic has become a serious concern and has negatively impacted
public health and the economy. It primarily targets the lungs, causing acute respiratory …

Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: An update

A Hernández-Díazcouder, C Díaz-Godínez… - Applied Microbiology …, 2023 - Springer
The lethality of the COVID 19 pandemic became the trigger for one of the most meteoric
races on record in the search for strategies of disease control. Those include development of …

The potential role of extracellular vesicles in COVID-19 treatment: opportunity and challenge

Y Yan, W Zhou, Y Wang, Q Guo, F Zhao… - Frontiers in Molecular …, 2021 - frontiersin.org
SARS-CoV-2 infection has become an urgent public health concern worldwide, severely
affecting our society and economy due to the long incubation time and high prevalence …

Exploiting extracellular vesicles strategies to modulate cell death and inflammation in COVID-19

B Bortot, A Romani, G Ricci, S Biffi - Frontiers in pharmacology, 2022 - frontiersin.org
The coronavirus disease (COVID-19) is responsible for more than 5 million deaths
worldwide, with respiratory failure being the most common clinical presentation. COVID-19 …

Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19

M Motallebnezhad, M Omraninava, HEG Ghaleh… - … -Research and Practice, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the cause of
coronavirus disease 2019 (COVID-19) which has emerged as a global health crisis …

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection

Y Leyfman, G Gohring, M Joshi, GP Menon… - Molecular Therapy, 2023 - cell.com
Severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) has infected over
650 million people and claimed the lives of nearly 7 million since the start of the pandemic …

SARS-CoV-2 and extracellular vesicles: An intricate interplay in pathogenesis, diagnosis and treatment

C Sbarigia, D Vardanyan, L Buccini… - Frontiers in …, 2022 - frontiersin.org
Extracellular vesicles (EVs) are widely recognized as intercellular communication mediators.
Among the different biological processes, EVs play a role in viral infections, supporting virus …